Camarda Financial Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-8,404
| Closed | -$2.21M | – | 64 |
|
|
2022
Q4 | $2.21M | Buy |
8,404
+918
| +12% | +$246K | 2.23% | 12 |
|
|
2022
Q3 | $1.69M | Sell |
7,486
-11,488
| -61% | -$2.78M | 1.98% | 12 |
|
|
2022
Q2 | $4.62M | Buy |
18,974
+8,957
| +89% | +$2.19M | 4.57% | 5 |
|
|
2022
Q1 | $2.42M | Buy |
10,017
+5,426
| +118% | +$1.25M | 1.16% | 22 |
|
|
2021
Q4 | $1.03M | Hold |
4,591
| – | – | 0.58% | 20 |
|
|
2021
Q3 | $976K | Sell |
4,591
-88
| -2% | -$20.3K | 0.66% | 16 |
|
|
2021
Q2 | $1.14M | Sell |
4,679
-14
| -0.3% | -$3.44K | 0.71% | 31 |
|
|
2021
Q1 | $1.17M | Buy |
4,693
+88
| +2% | +$21K | 0.84% | 26 |
|
|
2020
Q4 | $1.06M | Buy |
4,605
+18
| +0.4% | +$4.15K | 0.89% | 23 |
|
|
2020
Q3 | $1.17M | Hold |
4,587
| – | – | 1.42% | 18 |
|
|
2020
Q2 | $1.08M | Hold |
4,587
| – | – | 1.51% | 18 |
|
|
2020
Q1 | $930K | Hold |
4,587
| – | – | 4.7% | 8 |
|
|
2019
Q4 | $1.11M | Hold |
4,587
| – | – | 2.35% | 19 |
|
|
2019
Q3 | $888K | Hold |
4,587
| – | – | 2.07% | 24 |
|
|
2019
Q2 | $845K | Hold |
4,587
| – | – | 1.66% | 25 |
|
|
2019
Q1 | $871K | Sell |
4,587
-18
| -0.4% | -$3.44K | 1.66% | 21 |
|
|
2018
Q4 | $896K | Buy |
4,605
+18
| +0.4% | +$3.51K | 1.06% | 25 |
|
|
2018
Q3 | $951K | Hold |
4,587
| – | – | 1.08% | 21 |
|
|
2018
Q2 | $847K | Hold |
4,587
| – | – | 0.89% | 30 |
|
|
2018
Q1 | $782K | Hold |
4,587
| – | – | 0.81% | 33 |
|
|
2017
Q4 | $798K | Sell |
4,587
-108
| -2% | -$19.1K | 0.96% | 30 |
|
|
2017
Q3 | $875K | Hold |
4,695
| – | – | 0.94% | 29 |
|
|
2017
Q2 | $809K | Sell |
4,695
-66
| -1% | -$10.7K | 0.87% | 30 |
|
|
2017
Q1 | $781K | Sell |
4,761
-8,954
| -65% | -$1.49M | 0.76% | 39 |
|
|
2016
Q4 | $2M | Sell |
13,715
-2,149
| -14% | -$323K | 1.36% | 16 |
|
|
2016
Q3 | $2.65M | Sell |
15,864
-1,076
| -6% | -$182K | 1.61% | 13 |
|
|
2016
Q2 | $2.58M | Buy |
16,940
+1,163
| +7% | +$181K | 1.63% | 16 |
|
|
2016
Q1 | $2.37M | Buy |
15,777
+459
| +3% | +$68.2K | 1.47% | 15 |
|
|
2015
Q4 | $2.49M | Sell |
15,318
-593
| -4% | -$93.2K | 1.52% | 16 |
|
|
2015
Q3 | $2.2M | Sell |
15,911
-347
| -2% | -$54.7K | 1.37% | 18 |
|
|
2015
Q2 | $2.5M | Sell |
16,258
-1,667
| -9% | -$267K | 1.39% | 16 |
|
|
2015
Q1 | $2.87M | Sell |
17,925
-2,366
| -12% | -$373K | 1.59% | 15 |
|
|
2014
Q4 | $3.23M | Sell |
20,291
-2,554
| -11% | -$398K | 2.05% | 14 |
|
|
2014
Q3 | $3.21M | Buy |
22,845
+491
| +2% | +$64.1K | 2.23% | 13 |
|
|
2014
Q2 | $2.65M | Sell |
22,354
-4,044
| -15% | -$468K | 1.81% | 13 |
|
|
2014
Q1 | $3.26M | Buy |
26,398
+7,354
| +39% | +$892K | 2.5% | 10 |
|
|
2013
Q4 | $2.17M | Buy |
19,044
+466
| +3% | +$53K | 1.77% | 21 |
|
|
2013
Q3 | $2.08M | Buy |
18,578
+878
| +5% | +$95.2K | 2.72% | 10 |
|
|
2013
Q2 | $1.75M | Buy |
+17,700
| New | +$1.84M | 1.6% | 23 |
|
Other funds holding AMGN
Camarda Financial Advisors's AMGN Position: Q1 2023 in Review
Camarda Financial Advisors sold out of Amgen (AMGN) in Q1 2023, closing a stake of 8,404 shares — an estimated $2.21M sold.
Camarda Financial Advisors first reported a position in AMGN in Q2 2013 and held it in 39 quarters. The position peaked at $4.62M in Q2 2022. 2,435 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.
- Camarda Financial Advisors reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
- Camarda Financial Advisors sold 8,404 Amgen shares in Q1 2023, an estimated $2.21M.
- Camarda Financial Advisors first reported a position in Amgen in Q2 2013 and held it in 39 quarters.
- Camarda Financial Advisors's Amgen position peaked at $4.62M in Q2 2022.
- 2,435 funds tracked by Wall St. Rank held Amgen as of Q1 2023.
Based on Camarda Financial Advisors's 13F filing for Q1 2023, filed 11 May 2023.